ACE2 (IN1) Peptide
|
Login
|
ACE2 (IN1) Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-3215P-0.05mg |
Amount |
0.05 mg |
Available |
|
|
SARS (IN1) Spike Peptide
|
Login
|
SARS (IN1) Spike Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-3221P-0.05mg |
Amount |
0.05 mg |
Available |
|
|
SARS (IN2) Spike Peptide
|
Login
|
SARS (IN2) Spike Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-3223P-0.05mg |
Amount |
0.05 mg |
Available |
|
|
SARS (IN3) Spike Peptide
|
Login
|
SARS (IN3) Spike Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-3225P-0.05mg |
Amount |
0.05 mg |
Available |
|
|
ACE2 (IN2) Peptide
|
Login
|
ACE2 (IN2) Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-3229P-0.05mg |
Amount |
0.05 mg |
Available |
|
|
SARS-CoV-2 (2019-nCoV) NP Antibody
|
Login
|
SARS-CoV-2 (2019-nCoV) NP Antibody
|
Type |
Antibody Monoclonal |
Clone |
|
Specific against |
other
|
Appl. |
IS |
Host |
Cultured in vitro under conditions free from animal derived components. |
Item no. |
DA027-1mg |
Amount |
1mg |
Available |
|
|
SARS-CoV-2 (2019-nCoV) NP Antibody
|
Login
|
SARS-CoV-2 (2019-nCoV) NP Antibody
|
Type |
Antibody Monoclonal |
Clone |
|
Specific against |
other
|
Appl. |
IS |
Host |
Cultured in vitro under conditions free from animal derived components. |
Item no. |
DA027-500ug |
Amount |
500ug |
Available |
|
|
SARS-CoV-2 (2019-nCoV) NP Antibody
|
Login
|
SARS-CoV-2 (2019-nCoV) NP Antibody
|
Type |
Antibody Monoclonal |
Clone |
|
Specific against |
other
|
Appl. |
IS |
Host |
Cultured in vitro under conditions free from animal derived components. |
Item no. |
DA027-50ug |
Amount |
50ug |
Available |
|
|
GM-CSF Recombinant Protein
|
Login
|
GM-CSF Recombinant Protein
|
Type |
Proteins Recombinant |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
PRS-90-553-50ug |
Amount |
50 ug |
Available |
|
|
IL-2 Recombinant Protein
|
Login
|
IL-2 Recombinant Protein
|
Type |
Proteins Recombinant |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
PRS-90-554-50ug |
Amount |
50 ug |
Available |
|
|
IL-10 Recombinant Protein
|
Login
|
IL-10 Recombinant Protein
|
Type |
Proteins Recombinant |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
PRS-90-555-10ug |
Amount |
10 ug |
Available |
|
|
IL-33 Recombinant Protein
|
Login
|
IL-33 Recombinant Protein
|
Type |
Proteins Recombinant |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
PRS-90-557-10ug |
Amount |
10 ug |
Available |
|
|
IL-33 Recombinant Protein
|
Login
|
IL-33 Recombinant Protein
|
Type |
Proteins Recombinant |
Clone |
|
Specific against |
other
|
Appl. |
|
Host |
|
Item no. |
PRS-90-558-10ug |
Amount |
10 ug |
Available |
|
|
hRIP3 Peptide
|
Login
|
hRIP3 Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-8963P-0.05mg |
Amount |
0.05 mg |
Available |
|
|
IRF7 Peptide
|
Login
|
IRF7 Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-8991P-0.05mg |
Amount |
0.05 mg |
Available |
|
|
SARS-CoV-2 Spike Peptide
|
Login
|
SARS-CoV-2 Spike Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-9083P-0.05mg |
Amount |
0.05 mg |
Available |
|
|
SARS-CoV-2 Spike Peptide
|
Login
|
SARS-CoV-2 Spike Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-9087P-0.05mg |
Amount |
0.05 mg |
Available |
|
|
SARS-CoV-2 Spike Peptide
|
Login
|
SARS-CoV-2 Spike Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-9091P-0.05mg |
Amount |
0.05 mg |
Available |
|
|
SARS-CoV-2 Spike Peptide
|
Login
|
SARS-CoV-2 Spike Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-9095P-0.05mg |
Amount |
0.05 mg |
Available |
|
|
SARS-CoV-2 Nucleocapsid Peptide
|
Login
|
SARS-CoV-2 Nucleocapsid Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-9099P-0.05mg |
Amount |
0.05 mg |
Available |
|
|
SARS-CoV-2 Nucleocapsid Peptide
|
Login
|
SARS-CoV-2 Nucleocapsid Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-9103P-0.05mg |
Amount |
0.05 mg |
Available |
|
|
SARS-CoV-2 Spike S2 Peptide
|
Login
|
SARS-CoV-2 Spike S2 Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-9119P-0.05mg |
Amount |
0.05 mg |
Available |
|
|
SARS-CoV-2 Spike S2 Peptide
|
Login
|
SARS-CoV-2 Spike S2 Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-9123P-0.05mg |
Amount |
0.05 mg |
Available |
|
|
SARS-CoV-2 (COVID-19) 3CL-PRO (NSP5) Peptide
|
Login
|
SARS-CoV-2 (COVID-19) 3CL-PRO (NSP5) Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-9151P-0.05mg |
Amount |
0.05 mg |
Available |
|
|
SARS-CoV-2 (COVID-19) 3CL-PRO (NSP5) Peptide
|
Login
|
SARS-CoV-2 (COVID-19) 3CL-PRO (NSP5) Peptide
|
Type |
Peptides |
Clone |
|
Specific against |
other
|
Appl. |
Blocking |
Host |
|
Item no. |
PRS-9153P-0.05mg |
Amount |
0.05 mg |
Available |
|
|